Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statistics
Boston University · Baim Institute for Clinical Research
Abstract
Placebo-controlled trials are the ideal for evaluating medical treatment efficacy. They allow for control of the placebo effect and are most efficient, requiring the smallest numbers of patients to detect a treatment effect. A placebo control is ethically justified if no standard treatment exists, if the standard treatment has not been proven efficacious, there are no risks associated with delaying treatment or escape clauses are included in the protocol. Where possible and justified, they should be the first choice for medical treatment evaluation. Given the large number of proven effective treatments, placebo-controlled trials are often unethical. In these situations active-controlled trials are generally…
Citation impact
- FWCI
- 12.71
- Percentile
- 100%
- References
- 46
Authors
3Topics & keywords
- Placebo
- Clinical trial
- Assay sensitivity
- Medicine
- Margin (machine learning)
- Protocol (science)
- Randomized controlled trial
- Intensive care medicine
- Good health and well-being